Your browser doesn't support javascript.
loading
Body Composition and Metabolomics in the Alberta Physical Activity and Breast Cancer Prevention Trial.
McClain, Kathleen M; Friedenreich, Christine M; Matthews, Charles E; Sampson, Joshua N; Check, David P; Brenner, Darren R; Courneya, Kerry S; Murphy, Rachel A; Moore, Steven C.
Afiliação
  • McClain KM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Friedenreich CM; Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Edmonton, AB, Canada.
  • Matthews CE; Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Check DP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Brenner DR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Courneya KS; Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Murphy RA; Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, Canada.
  • Moore SC; School of Population and Public Health, The University of British Columbia, Vancouver, BC, Canada.
J Nutr ; 152(2): 419-428, 2022 02 08.
Article em En | MEDLINE | ID: mdl-34791348
ABSTRACT

BACKGROUND:

Obesity is correlated with many biomarkers, but the extent to which these correlate with underlying body composition is poorly understood.

OBJECTIVES:

Our objectives were to 1) describe/compare distinct contributions of fat/lean mass with BMI-metabolite correlations and 2) identify novel metabolite biomarkers of fat/lean mass.

METHODS:

The Alberta Physical Activity and Breast Cancer Prevention Trial was a 2-center randomized trial of healthy, inactive, postmenopausal women (n = 304). BMI (in kg/m2) was calculated using weight and height, whereas DXA estimated fat/lean mass. Ultra-performance liquid chromatography and mass spectrometry measured relative concentrations of serum metabolite concentrations. We estimated partial Pearson correlations between 1052 metabolites and BMI, adjusting for age, smoking, and site. Fat mass index (FMI; kg/m2) and lean mass index (LMI; kg/m2) correlations were estimated similarly, with mutual adjustment to evaluate independent effects.

RESULTS:

Using a Bonferroni-corrected α level <4.75 × 10-5,  we observed 53 BMI-correlated metabolites (|r| = 0.24-0.42). Of those, 21 were robustly correlated with FMI (|r| > 0.20), 25 modestly (0.10 ≤ |r| ≤ 0.20), and 7 virtually null (|r| < 0.10). Ten of 53 were more strongly correlated with LMI than with FMI. Examining non-BMI-correlated metabolites, 6 robustly correlated with FMI (|r| = 0.24-0.31) and 2 with LMI (r = 0.25-0.26). For these, correlations for fat and lean mass were in opposing directions compared with BMI-correlated metabolites, in which correlations were mostly in the same direction.

CONCLUSIONS:

Our results demonstrate how a thorough evaluation of the components of fat and lean mass, along with BMI, provides a more accurate assessment of the associations between body composition and metabolites than BMI alone. Such an assessment makes evident that some metabolites correlated with BMI predominantly reflect lean mass rather than fat, and some metabolites related to body composition are not correlated with BMI. Correctly characterizing these relations is important for an accurate understanding of how and why obesity is associated with disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article